Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2024 Mar 20;14:1399853. doi: 10.3389/fonc.2024.1399853

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

Frontiers Editorial Office*
PMCID: PMC10992999  PMID: 38577339

Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that they discovered a fault in their experimental design that rendered the conclusion unreliable. An investigation was conducted in accordance with Frontiers’ policies that confirmed this; therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Oncology and the Chief Executive Editor of Frontiers. The authors agree to proceed with the retraction and sincerely regret any inconvenience this may have caused to the reviewers, editors and readers of Frontiers in Oncology.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES